APA
AZN icon

American Portfolios Advisors’s AstraZeneca AZN Stock Holding History

American Portfolios Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1.41M Sell
12,888
-762
-6% -$96.7K 0.06% 319
2022
Q2 		$1.8M Sell
13,650
-17
-0.1% -$2.23K 0.07% 269
2022
Q1 		$1.81M Buy
13,667
+2,365
+21% +$284K 0.06% 307
2021
Q4 		$1.32M Buy
11,302
+2,223
+24% +$262K 0.04% 398
2021
Q3 		$1.09M Buy
9,079
+2,168
+31% +$252K 0.04% 429
2021
Q2 		$828K Buy
6,911
+288
+4% +$31.6K 0.03% 520
2021
Q1 		$659K Sell
6,623
-949
-13% -$95.4K 0.03% 552
2020
Q4 		$757K Sell
7,572
-2,375
-24% -$252K 0.04% 425
2020
Q3 		$1.09M Sell
9,947
-233
-2% -$25.9K 0.06% 273
2020
Q2 		$1.08M Buy
10,180
+4,049
+66% +$418K 0.07% 260
2020
Q1 		$548K Sell
6,131
-756
-11% -$71.2K 0.05% 345
2019
Q4 		$687K Buy
6,887
+45
+0.7% +$4.24K 0.05% 337
2019
Q3 		$610K Sell
6,842
-393
-5% -$34.1K 0.05% 345
2019
Q2 		$597K Sell
7,235
-136
-2% -$10.7K 0.05% 342
2019
Q1 		$596K Buy
7,371
+1,743
+31% +$137K 0.06% 323
2018
Q4 		$427K Sell
5,628
-494
-8% -$38.6K 0.05% 313
2018
Q3 		$484K Sell
6,122
-143
-2% -$10.8K 0.06% 322
2018
Q2 		$440K Sell
6,265
-44
-0.7% -$3.17K 0.06% 312
2018
Q1 		$441K Buy
6,309
+856
+16% +$59.3K 0.07% 287
2017
Q4 		$378K Buy
+5,453
New +$368K 0.06% 321

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

American Portfolios Advisors's AZN Position: Q3 2022 in Review

American Portfolios Advisors reduced its AstraZeneca (AZN) stake by 5.6% in Q3 2022, selling an estimated $96.7K and leaving 12,888 shares worth $1.41M. The position accounts for 0.06% of the portfolio, ranked #319.

American Portfolios Advisors first reported a position in AZN in Q4 2017 and has held it in 20 quarters since. The position peaked at $1.81M in Q1 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

  • American Portfolios Advisors held 12,888 shares of AstraZeneca worth $1.41M as of Q3 2022.
  • American Portfolios Advisors sold 762 AstraZeneca shares in Q3 2022, an estimated $96.7K.
  • AstraZeneca made up 0.06% of American Portfolios Advisors's portfolio in Q3 2022, its #319 holding.
  • American Portfolios Advisors first reported a position in AstraZeneca in Q4 2017 and has held it in 20 quarters since.
  • American Portfolios Advisors's AstraZeneca position peaked at $1.81M in Q1 2022.
  • 965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.